Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-010560
Filing Date
2021-10-18
Accepted
2021-10-18 17:00:46
Documents
1
Period of Report
2021-10-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-54023.html 4  
1 PRIMARY DOCUMENT marketforms-54023.xml 4 5811
  Complete submission text file 0001214659-21-010560.txt   7159
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Issuer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 ORCHARD STREET MENDHAM NJ 07945
Business Address
Oram Jeffrey (Reporting) CIK: 0001864444 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40483 | Film No.: 211328776